Oxybutynin Chloride Tablet, Extended Release
FDA Label NDC 68084-610

36 label sections · Submitted to the FDA by American Health Packaging · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by American Health Packaging for the product Oxybutynin Chloride (NDC 68084-610). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1 indications and usage, 2 dosage and administration, 2.1 adults, 2.2 pediatric patients aged 6 years of age and older, 3 dosage forms and strengths, 4 contraindications, 5.1 angioedema, 5.2 central nervous system effects, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel – Carton – 5 Mg – 50 Ud

NDC 68084- 480-65

Oxybutynin Chloride
Extended-Release Tablets USP

5 mg

50 Tablets (5 x 10)                 Rx Only

Each Tablet Contains:
5 mg oxybutynin chloride in an extended-release formulation.

Usual Dosage: Once daily. See full prescribing information.

Store at 20° to 25°C (68° to 77°F); excursions permitted between
15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
Protect from moisture and humidity.

FOR YOUR PROTECTION: Do not use if blister is torn or broken.

The drug product contained in this package is from
NDC # 62175-270, Lannett Company, Inc.

Distributed by: American Health Packaging, Columbus, Ohio 43217

048065
0248065/0824

Package/Label Display Panel – Carton – 5 Mg – 100 Ud

NDC 68084- 480-01

Oxybutynin Chloride
Extended-Release Tablets USP

5 mg

100 Tablets (10 × 10)                Rx Only

Each Tablet Contains:
5 mg oxybutynin chloride in an extended-release formulation.

Usual Dosage: Once daily. See full prescribing information.

Store at 20° to 25°C (68° to 77°F); excursions permitted between
15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
Protect from moisture and humidity.

FOR YOUR PROTECTION: Do not use if blister is torn or broken.

The drug product contained in this package is from
NDC # 62175-270, Lannett Company, Inc.

Distributed by: American Health Packaging, Columbus, Ohio 43217

048001
0248001/0824

Package/Label Display Panel – Blister – 5 Mg

Oxybutynin
Chloride
Extended-Release
Tablet USP

5 mg

Package/Label Display Panel – Carton – 10 Mg

NDC 68084- 610-21

Oxybutynin Chloride
Extended-Release Tablets USP

10 mg

30 Tablets (3 × 10)                 Rx Only

Each Tablet Contains:
10 mg oxybutynin chloride in an extended-release formulation.

Usual Dosage: Once daily. See full prescribing information.

Store at 20° to 25°C (68° to 77°F); excursions permitted between
15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
Protect from moisture and humidity.

FOR YOUR PROTECTION: Do not use if blister is torn or broken.

The drug product contained in this package is from
NDC # 62175-271, Lannett Company, Inc.

Distributed by: American Health Packaging, Columbus, Ohio 43217

061021
0261021/0824

Package/Label Display Panel – Blister – 10 Mg

Oxybutynin Chloride
Extended-Release
Tablet USP     10 mg

* Please review the disclaimer below.